Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
203 USD | -0.94% | -5.56% | -3.62% |
May. 31 | LIVESTOCK-CME cattle futures continue slump amid demand questions | RE |
May. 30 | LIVESTOCK-CME cattle turn lower as China allows some Russian beef imports | RE |
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- This company will be of major interest to investors in search of a high dividend stock.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Sales forecast by analysts have been recently revised upwards.
- For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
Weaknesses
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Financial & Commodity Market Operators
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-3.62% | 73.09B | B | ||
+19.95% | 23.23B | C+ | ||
+23.57% | 12B | C+ | ||
-1.13% | 8.03B | B- | ||
+26.02% | 7.53B | C+ | ||
+21.28% | 4.37B | C | ||
-7.19% | 2.81B | C+ | ||
+13.49% | 2.22B | C | ||
-8.84% | 1.63B | C | ||
+102.13% | 1.45B | - | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- CME Stock
- Ratings CME Group Inc.